Effects of ACTHAR on Advanced MRI Surrogate Markers of Disease Activity and on Comprehensive Immune Signature During MS Relapses
Condition(s):Multiple SclerosisLast Updated:January 19, 2017Unknown status
Hide Studies Not Open or Pending
Condition(s):Multiple SclerosisLast Updated:January 19, 2017Unknown status
Condition(s):Systemic Lupus Erythematosus (SLE); Repository Corticotropin InjectionLast Updated:September 13, 2019Withdrawn
Condition(s):SarcoidosisLast Updated:May 11, 2023Recruiting
Condition(s):Dermatomyositis; Juvenile DermatomyositisLast Updated:September 16, 2021Completed
Condition(s):UveitisLast Updated:September 27, 2018Unknown status
Condition(s):IgA Nephropathy; ProteinuriaLast Updated:April 5, 2017Withdrawn
Condition(s):Proliferative VitreoretinopathyLast Updated:August 8, 2023Completed
Condition(s):Multiple Sclerosis (MS)Last Updated:September 16, 2014Completed
Condition(s):Chronic MigraineLast Updated:July 26, 2018Completed
Condition(s):Rheumatoid ArthritisLast Updated:September 6, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.